This is the authors' abstract. We don't add key points for this paper.
Our study provides evidence that it is safe and feasible to apply an early PR in patients with acute exacerbation of COPD.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Zhongmin Qiu (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: